News

Our latest press releases, media appearances and topical commentary.





News
29 January 2018
CSO, Dr Peter Simpson, joins SLAS Board of Directors

Peter will be joining their board this year along with Emilio Diez Monedero and Severine Tamas-Lhoustau.





News
18 January 2018
The State of the Drug Discovery Nation unveiled as new report provides vital insights for the development of new medicines

The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five themes to help boost productivity.


News
11 January 2018
CEO Chris Molloy shares his vision for the future of Medicines Discovery

Our Chief Executive Officer, Chris Molloy, explores how Medicines Discovery Catapult is supporting the community to realise the future of drug discovery.


News
30 November 2017
‘The rise of Corporate Venture Capital (CVC) investment in UK biotech’ report now published by the Association of the British Pharmaceutical Industry (ABPI)

The amount of capital invested alongside CVC into UK companies increased six-fold between 2010 and 2015.


News
30 November 2017
Government’s Industrial Strategy White Paper Published

Chris Molloy responds to the Government’s Industrial Strategy White Paper.


News
30 August 2017
Medicines Discovery Catapult: Life Sciences Industrial Strategy

Statement from Medicines Discovery Catapult.


News
14 July 2017
How Catapults are working today, for tomorrow

Watch our new video introducing the Catapult programme, its centres and crucial work.






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult